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Abstract
Purpose—We determined whether variants in genes associated with genital tubercle (the anlage
for the penis) and early urethral development were associated with hypospadias in humans.
Materials and Methods—We examined 293 relatively common tagSNPs in BMP4, BMP7,
FGF8, FGF10, FGFR2, HOXA13, HOXD13, HOXA4, HOXB6, SRY, WT1, WTAP, SHH, GLI1,
GLI2, and GLI3. The analysis included 624 cases (81 mild, 319 moderate, 209 severe, 15
undetermined severity) and 844 population-based non-malformed male controls born in California
from 1990-2003.
Results—There were 28 SNPs for which any of the comparisons (i.e., overall or for a specific
severity) had a p-value <0.01. The homozygous variant genotypes for four SNPs in BMP7 were
associated with at least 2-fold increased risk of hypospadias, regardless of severity. Five SNPs for
FGF10 were associated with 3- to 4-fold increased risks, regardless of severity; for four of them,
results were restricted to whites. For GLI1, GLI2 and GLI3, there were 12 associated SNPs but
results were inconsistent by severity and race-ethnicity. For SHH, one SNP was associated with
2.4-fold increased risk of moderate hypospadias. For WT1, six SNPs were associated with
approximately 2-fold increased risks, primarily for severe hypospadias.
Conclusions—This study provides evidence that SNPs in several genes that contribute to
genital tubercle and early urethral development are associated with hypospadias risk.
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Hypospadias is a common congenital malformation in which the urethral meatus is on the
ventral side of the penis 1, 2. Familial patterns indicate that genetic factors substantially
contribute to its etiology 3.
Early development of the external genitalia and urethra depends on the formation and
outgrowth of the genital tubercle, the anlage for the penis. This early stage is largely
androgen-independent and precedes sexual differentiation. Experimental studies support the
contribution of many transcription factors and signaling molecules to this process, including
Wilms tumor 1, sonic hedgehog, homeobox proteins, bone morphogenetic proteins,
fibroblast growth factors, and Gli transcription factors 4-9. Expression of the sex-determining
region Y gene (SRY) and its direct target, SOX9, is critical to the initiation of the next phase,
which is androgen-dependent and involves sexual differentiation and development of the
penis and testes 10. Previous studies have investigated the association of hypospadias with
genes that contribute to these events. A greater frequency of variants in cases than controls
has been reported for BMP4, BMP7, HOXA4, HOXA6, and WT1 but not SRY or SOX9
among Chinese males 11, 12, FGF8 and FGFR2 but not BMP7 or FGF10 among Swedish
males 13, and one study did not observe differences among German males for HOXA13 or
WTAP 14. Severity of the phenotypes varied. These studies have primarily involved
sequencing, among few subjects. 15.
Our hypothesis was that variants in genes associated with genital tubercle and early urethral
development are associated with human hypospadias. We examined close to 300 relatively
common variants in a large population of California male infants in the following genes,
given that they have been the subject of previous genetic association studies in humans:
BMP4, BMP7, FGF8, FGF10, FGFR2, HOXA13, HOXD13, HOXA4, HOXB6, SRY and
SOX9, WT1, and WTAP. We also examined SHH, GLI1, GLI2, and GLI3 (Table 1).
MATERIALS AND METHODS
The study population included male infants born from 1990-2003 to mothers who were
residents of eight California Central Valley counties and from 1990-1997 to mothers who
were residents of Los Angeles, San Francisco, and Santa Clara counties, reflecting counties
where case ascertainment was actively conducted by the California Birth Defects
Monitoring Program (CBDMP) by reviewing medical records at hospitals and genetic
centers 16.
Cases were classified as mild (meatus was limited to the coronal or glanular penis, British
Pediatric Association [BPA] codes 752.605, 752.625), moderate (meatus on the penile shaft,
BPA 752.606, 752.626), or severe (meatus at the peno-scrotal junction or perineal area, BPA
752.607, 752.627). Assignment of severity was finalized based on review by a medical
geneticist (EJL or Dr. Cynthia Curry) 17. Cases for which the anatomical position was not
sufficiently described (“not-otherwise-specified,” BPA codes 752.600, 752.620) were
excluded. Cases classified as having a known single gene disorder or chromosomal
abnormality were excluded. Mild cases without chordee (BPA752.605) were not ascertained
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by CBDMP except in 2004; thus, mild cases are under-represented and primarily those with
chordee 17.
The underlying study population included 1,246,172 non-malformed live born male infants
eligible for control selection. We randomly selected 931 with available bloodspots (the DNA
source), in proportion to the underlying birth population for each year, to give an
approximate 2:1 ratio of controls to cases from Central Valley counties and a 1:1 ratio from
other counties. The ratio differed due to the presence of a secondary on-going study in the
Central Valley.
Covariates were from birth certificates: maternal race-ethnicity, education, age, and parity;
plurality; and infant birthweight and gestational age at delivery. In total, 667 (88% of
eligible) cases and 931 (93% of eligible) controls were available for genotyping.
Genomic DNA was extracted from dried bloodspots using MasterPure™ Complete DNA
and RNA Purification Kit (Epicentre Biotechnologies Madison, WI), and 10 ng genomic
DNA was then used for whole genome amplification (Qiagen Repli-g® kit). TagSNPs that
assay known common SNPs either directly or indirectly via linkage disequilibrium among
measured and unmeasured SNPs were selected (http://gvs.gs.washington.edu/GVS/). The
program provided tagSNPs that cover common variation at r2>0.80 across each candidate
gene for a “cosmopolitan” population, including Hispanics. TagSNPs with minor allele
frequencies (MAF) >10% were selected. For FGF10 and SRY we selected tagSNPs with
MAF>1% because none had MAF>10%. For GLI2 and GLI3 we excluded the Yoruban
(YRI) population from tagSNP selection to reduce the number of SNPs (both genes initially
produced >100 tagSNPs). For FGFR2, we limited SNP selection to 2 non-intronic tagSNPs
due to limited assay space. SNPs were genotyped using a custom multiplex Illumina
GoldenGate assay.
We started with 324 SNPs. We excluded 19 for which the data indicated poor clustering of
results and one with a call rate <90%. We also excluded 126 subjects (41 cases, 85 controls)
with sample call rates <90%, leaving 626 cases and 846 controls for analyses. We further
excluded 11 SNPs with p<0.01 for Hardy-Weinberg test of equilibrium among non-Hispanic
white or Hispanic controls, leaving 293 for analysis. The single SNP we measured for SOX9
was excluded based on the Hardy-Weinberg test.
Following our previous work, we genotyped 106 ancestry informative marker (AIM) SNPs
to discriminate Native American, African, and European ancestry 18-21, and we used
Structure 2.1 to estimate individual ancestry estimates (IAE) 22, 23. Four SNPs were
excluded that had call rates <90%. Structure was run using the admixture model with
unlinked markers, with 50,000 burn-in iterations and 50,000 further iterations. Structure
provided variables reflecting the proportions of Native American, African and European
ancestry for each subject. Given that the three proportions sum to one, analyses included
only two (Native American and African).
We used logistic regression to compare homozygous and heterozygous variant genotypes
with homozygous wildtype (the more frequent allele among controls was designated as
wildtype). We considered the presence of population stratification by examining models
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restricted to self-identified non-Hispanic white and Hispanic subjects that contained product
terms to estimate interaction. For SNPs for which the overall p-value for the product term
was <0.10 (n=21), we focused on stratified results. We conducted analyses of all cases
grouped together as well as separately by severity.
For the 9 genes for which there were >5 SNPs (BMP7, FGF8, FGF10, HOXB6, GLI1, GLI2,
GLI3, WT1, WTAP), we examined haplotypes. We used Haploview 4.2 to determine the LD
structure and to define haplotype blocks and their frequencies based on all subjects’
genotypes 24. The most common haplotype was the reference. Maximum likelihood
estimates of odds ratios (OR) and their corresponding 95% confidence intervals (CI) were
calculated from logistic regression models to estimate relative risks.
We also evaluated genetic risk scores created by combining high-risk SNPs. For each
individual we counted the number of genes in which they carried an associated variant
(p<0.01). For variants with ORs<1, the reference genotype (homozygous wildtype) was
scored as the risk genotype. We calculated scores overall and separately by severity
(applying the p-value criterion within each group, such that a somewhat different set of
variants was scored within each group). We then estimated ORs and 95% CIs associated
with the risk scores, using logistic regression.
All ORs were adjusted for the two ancestral proportion variables and for maternal residence
in the Central Valley due to the differing case-control ratio based on this variable inherent to
the study design. In addition, non-stratified results were adjusted for maternal race-ethnicity
(Hispanic, non-Hispanic white, or other). Two cases and two controls had missing race-
ethnicity, such that SNP-based analyses included 844 controls and a maximum 624 cases
(81 mild, 319 moderate, 209 severe, 15 undetermined).
The study was approved by the California Health and Human Services Agency Committee
for the Protection of Human Subjects and Institutional Review Boards at Stanford
University and Children’s Hospital Oakland.
RESULTS
Comparing case versus control mothers, the former were more likely non-Hispanic white,
more highly educated, older, and nulliparous (Table 2). Cases were more likely to be low
birthweight and delivered before 37 weeks of gestation.
There were 28 SNPs for which any comparison had p<0.01 (Table 3). (Results for other
SNPs are available in a supplementary table). The homozygous variant genotypes for four
SNPs in BMP7 were associated with at least 2-fold increased risk of hypospadias, regardless
of severity. Five SNPs for FGF10 were associated with 3-4-fold increased risks, regardless
of severity; for four of these, results were restricted to whites. For GLI1, six SNPs were
associated: three with reduced risk and three with increased risk, primarily among moderate
cases. For GLI2, two SNPs were associated with 2-fold increased risks for moderate
phenotypes, but only among whites, and one SNP was associated with 2-fold increased risk,
but only for moderate hypospadias (severe phenotypes were also associated with increased
risk for two of the SNPs, albeit p>0.01). For GLI3, one SNP was associated with increased
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risk of mild, one with moderate, and one with severe hypospadias. For SHH, one SNP was
associated with increased risk of moderate hypospadias. For WT1, six SNPs were associated
with approximately 2-fold increased risk, primarily for severe hypospadias.
The similarity in results across multiple SNPs for certain genes reflected high linkage
disequilibrium in some instances but not others. For example, for BMP7 the pair-wise R-
squared values for three of the four SNPs ranged from 0.83 to 0.95 (the fourth SNP,
rs607007, was rare). For the other genes, the ranges were as follows: 0.43-0.97 for FGF10;
0.54-0.91 for GLI1; 0.28-0.65 for GLI2; 0.03-0.09 for GLI3; and 0.48-0.86 for WT1, with
the exception of rs12293750, for which there was only one homozygous variant subject
(data not shown).
Haplotype analyses, which included all cases as one group, produced two results with
p<0.01. For a block in GLI3 that included rs2237421, rs2237420, rs1527499 and rs3801165,
the OR for the ACTG haplotype versus ACGG was 1.5 (95% CI 1.1, 2.0), p=0.0079. For a
block in WTAP that included rs963800, rs2758313, rs2842972, rs4709364, rs3822849 and
rs1440, the OR for the CCCCTG versus CCTCTG haplotype was 3.3 (95% CI 1.5, 7.3),
p=0.002.
Results for the risk score analysis reflect the increase in risk due to having risk-associated
SNPs in multiple genes (Table 4). As expected, a higher number of risk genes corresponded
with higher ORs. For example, among severe cases a score of two or three was associated
with at least a 3-fold increased risk, whereas a score of one was associated with a 1.6-fold
increased risk.
DISCUSSION
SNPs in several genes that contribute to genital tubercle and early urethral development
were associated with hypospadias risk, including BMP7, FGF10, GLI transcription factors,
SHH and WT1. Results did not suggest an association with BMP4, FGF8, FGFR2, SRY or
WTAP. This study included a more in-depth investigation of variants in these genes than
previous studies, in a large, racially-ethnically diverse study population.
Experimental studies indicate that bone morphogenetic proteins and fibroblast growth
factors contribute to genital tubercle development 4, 6. Two studies have examined their
contribution to hypospadias in humans. Sequence variations in BMP4 were reported among
three cases and in BMP7 among six cases, out of 90, and none among 190 controls 11.
Among 60 Swedish boys with familial, isolated hypospadias, four had variants in FGF8 and
seven had variants in FGFR2, which were not observed among 96 controls 13. Several
FGFR2 relatively frequent polymorphisms were observed but not different among cases
versus controls. No sequence variations were reported in FGF10 or BMP7 13. In the current
study, SNPs in BMP4, FGF8, and FGFR2 were not associated with hypospadias, whereas,
several SNPs in BMP7 and FGF10 were associated with at least 2-fold increased risks of
hypospadias, regardless of severity. Findings for FGF10 were predominately among non-
Hispanic whites.
Carmichael et al. Page 5






















SHH contributes to epithelial-mesenchymal interactions and patterning in the genital
tubercle 25, and Shh knockout mice have genital tubercle agenesis 9. Gli transcription factors
are encoded by three genes with overlapping function (GLI1-3), which are regulated by SHH
25. GLI genes are associated with limb and craniofacial development, which involve
developmental processes related to tissue patterning that may apply to urethral
development 25. Gli2 mutant mice have defective urethral formation 9, 25. To our
knowledge, the current study represents the first investigation of GLI1-3 or SHH and
hypospadias in humans. Our study provided some evidence of an association for selected
variants in these genes, but results were inconsistent across phenotypes and race-ethnicity.
WT1 is a zinc-finger transcription factor that contributes to normal development of the
genitourinary system 26, 27. WTAP contributes to WT1 function 28. Sequence variations in
WT1 were reported in three of 90 Chinese cases and zero of 276 controls 12, and zero of 35
Swedish cases 29. Variants in WT1 were reported among six of 80 severe hypospadias cases
with cryptorchidism; all six eventually developed Wilms tumor or nephropathy 30. No
variants were observed among 70 cases without cryptorchidism. Utsch et al. sequenced the
exons of WTAP 14. They observed two variants and stated that their frequency was not
different between cases and controls. In the current study, a WTAP haplotype and several
SNPs in WT1 were associated with hypospadias.
Experimental evidence also suggests that homeobox genes contribute to early genital
tubercle development 4, 5. Hoxa13 knockout mice have hypospadias 4, and Hoxa13 mutants
have altered androgen receptor expression 4. In humans, mutations in HOXA13 cause hand-
foot-genital syndrome, which includes hypospadias 5. However, no sequence variants in
HOXA13 were observed among 37 cases with hypospadias 14. Variants in HOXA4 were
observed among three subjects and in HOXA6 among two subjects, among 90 total, and
none among controls 11. The current study did not provide support for an association of
common variants in several homeobox genes with hypospadias.
Our study is strengthened by its size, population-based controls, ancestry informative
markers, and inclusion of multiple genes. We chose to highlight results that met a relatively
modest criterion for statistical significance (p<0.01) rather than conducting formal
correction for multiple testing, given that our study focused on candidate genes. Our
approach minimizes Type II errors (false negatives). However, we acknowledge that the
trade-off is an increased possibility of false positive results. As such, we emphasize the need
for replication of our findings in additional study populations. Our approach of investigating
tagSNPs seemed appropriate, given that it captures the majority of genetic variation and is
cost-efficient, and that minimal examination of the studied genes in humans preceded the
current study. However, most tagSNPs are intronic and have no known functional
consequences. Two exonic SNPs are included in Table 3 but are non-synonymous variants
(rs2228226 in GLI1 and rs16754 in WT1). Thus, observed associations are likely driven by
linkage disequilibrium with other less common unmeasured variants and merit further
genetic inquiry. Elucidation of underlying causal variants could be useful for genetic
counseling purposes or for directing mechanistic studies. Also of note, we were able to
explore results by phenotypic severity, but sample size for some phenotype-specific results
were limited, especially for mild cases. Under-ascertainment of mild cases or
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misclassification of severity are potential limitations but unlikely to be responsible for our
results.
CONCLUSIONS
This study found substantial evidence for an association of hypospadias with genes involved
in genital tubercle development.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Genes included in analyses.
Gene name Gene symbol Role Number of SNPs analyzed
(total=293)
Bone morphogenetic protein 4 BMP4 GT signaling cascade 3
Bone morphogenetic protein 7 BMP7 GT signaling cascade 62
Fibroblast growth factor 10 FGF10 GT signaling cascade 25
Fibroblast growth factor 8 FGF8 GT signaling cascade 7
Fibroblast growth factor receptor 2 FGFR2 GT signaling cascade 1
GLI family zinc finger 1 GLI1 GT signaling cascade, 7
GLI family zinc finger 2 GLI2 GT signaling cascade 45
GLI family zinc finger 3 GLI3 GT signaling cascade 91
Homeobox A13 HOXA13 GT signaling cascade 3
Homeobox D13 HOXD13 GT signaling cascade 2
Homeobox A4 HOXA4 GT signaling cascade, penile skin deveopment 3
Homeobox B6 HOXB6 GT signaling cascade, penile skin development 6
Sonic hedgehog SHH GT signaling cascade 3
Sex determining region Y SRY Initiation of sexual differentiation stage 1
Wilms tumor 1 WT1 Early GT development 27
Wilms tumor 1 associated protein WTAP Early GT development 7
GT = genital tubercle
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Table 2
Descriptive characteristics of cases with hypospadias (n=626) and non-malformed controls (n=846).
Percent of Controls (n) Percent of Cases (n)
Maternal race-ethnicity
 White 31 (258) 44 (274)
 Hispanic 52 (439) 34 (215)
 Others 17 (147) 22 (135)
 Unknown <1 (2) <1 (2)
Maternal education
 < High school 39 (330) 25 (159)
 High school 31 (265) 27 (170)
 > High school 29 (244) 47 (295)
 Unknown <1 (7) <1 (2)
Maternal age
 < 25 years 46 (393) 30 (185)
 25-34 years 43 (360) 52 (329)
 35 or more years 11 (93) 18 (112)
Number of previous live births
 0 36 (308) 52 (328)
 1 33 (275) 26 (162)
 ≥ 2 31 (263) 21 (134)
 Unknown 0 (0) <1 (2)
Infant birthweight
 ≤ 2500 g 5 (42) 30 (190)
 > 2500 g 95 (804) 70 (436)
Gestational age at delivery
 < 37 weeks 7 (60) 23 (143)
 ≥ 37 weeks 89 (750) 74 (462)
 Unknown 4 (36) 3 (21)
Maternal residence in Central Valley
 No 45 (381) 63 (392)
 Yes 55 (465) 37 (234)
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Table 4
Association of risk scores overall and within specific phenotypes.*
Score No. Cases No. Controls OR (95% CI)
All Cases 0 453 726 Reference
1 144 106 2.0 (1.5, 2.7)
2 23 12 2.5 (1.2, 5.4)
3 4 0 undefined
Mild Cases 0 61 764 Reference
1 18 74 3.5 (1.8, 7.0)
2 2 6 6.0 (0.9, 41.8)
Moderate Cases 0 104 339 Reference
1 130 367 1.5 (1.1, 2.2)
2 59 112 2.8 (1.8, 4.3)
3 22 24 8.1 (3.8, 17.0)
4 4 2 32.6 (5.0, 211.4)
Severe Cases 0 66 404 Reference
1 93 352 1.6 (1.1, 2.3)
2 47 82 3.4 (2.1, 5.6)
3 3 6 3.7 (0.8, 16.2)
*
Risk scores reflect the number of genes for which an individual had a variant genotype that had a p-value <0.01 (see Table 3 for variants that met
this criterion). The maximum possible scores were 4, 2, 6, and 4 for all, mild, moderate and severe cases, respectively. All odds ratios were
adjusted for the two ancestral proportion variables, maternal residence in the Central Valley (yes/no), and maternal race-ethnicity (Hispanic, non-
Hispanic white, or other) if the results were not already stratified.
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